The hormonal response and proliferation status of the PDXs were further confirmed with Ki67 staining and serum prostate-specific antigen (PSA) level, and the B7-H3 downregulation in 12-week post-Cx dormant PCa PDXs was confirmed with Western blot analysis (Fig. 2C). The gene discussed is CD276; the disease is posterior cortical atrophy.